Supplementary Figure 25 from Ultrasensitive Detection of Circulating LINE-1 ORF1p As a Specific Multicancer Biomarker
Martin S. Taylor,Connie Wu,Peter C. Fridy,Stephanie J. Zhang,Yasmeen Senussi, Justina C. Wolters,Tatiana Cajuso, Wen-Chih Cheng, John D. Heaps, Bryant D. Miller, Kei Mori,Limor Cohen, Hua Jiang,Kelly R. Molloy,Brian T. Chait, Michael G. Goggins,Irun Bhan,Joseph W. Franses, Xiaoyu Yang,Mary-Ellen Taplin,Xinan Wang,David C. Christiani,Bruce E. Johnson, Matthew Meyerson,Ravindra Uppaluri,Ann Marie Egloff,Elyssa N. Denault,Laura M. Spring,Tian-Li Wang,Ie-Ming Shih, Jennifer E. Fairman,Euihye Jung,Kshitij S. Arora,Osman H. Yilmaz,Sonia Cohen,Tatyana Sharova,Gary Chi, Bryanna L. Norden, Yuhui Song, Linda T. Nieman, Leontios Pappas,Aparna R. Parikh,Matthew R. Strickland,Ryan B. Corcoran,Tomas Mustelin,George Eng,Ömer H. Yilmaz,Ursula A. Matulonis,Andrew T. Chan,Steven J. Skates,Bo R. Rueda,Ronny Drapkin,Samuel J. Klempner,Vikram Deshpande,David T. Ting,Michael P. Rout,John LaCava,David R. Walt,Kathleen H. Burns crossref（2024）
摘要
Second round of screening of newly developed “3rd generation” assays using dimeric nanobody detectors.
更多查看译文
关键词
Biosensors,cancer diagnostics
AI 理解论文
溯源树
样例
